[1]
Ahumada-Pascual P, García-Ganan D, Berdei-Montero Y, Velasco A. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP. Curr Pharm Des 2019; 25(4): 376-80.
[2]
Tomasetti C, Montemitro C, Fiengo ALC, et al. Novel pathways in the treatment of major depression: focus on the glutamatergic system. Curr Pharm Des 2019; 25(4): 381-7.
Current Pharmaceutical Design
Title:Neural Networks in Neurological and Psychiatric Diseases
Volume: 25 Issue: 4
Author(s): Felix-Martin Werner
Affiliation:
Export Options
About this article
Cite this article as:
Werner Felix-Martin , Neural Networks in Neurological and Psychiatric Diseases , Current Pharmaceutical Design 2019; 25 (4) . https://dx.doi.org/10.2174/138161282504190516080951
DOI https://dx.doi.org/10.2174/138161282504190516080951 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
19
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements